Your A-Z of episodes

Peruse previous podcasts and tune into the people and topics that spark your interest. Each episode offers a brief synopsis to help you select the conversation that best fits your schedule. With most episodes lasting around 40 minutes you can scan the sector and listen to leaders while you commute, exercise or grocery shop. Select your shot of infotainment.

  • Episode 47

    2021 mid-year CDMO review

    Jim Miller

    / PharmSource

    In today’s special ‘bite-sized’ Molecule to Market episode, I’ll be talking with Jim Miller about the CDMO space at the half point mark in 2012. Inspired by this terrific article https://www.dcatvci.org/7173-mid-year-cdmo-review-covid-19-vaccine-manufacturing-and-m-a on the DCAT ValueChain Insights websites, Jim covers: Vaccine manufacturing, capacity constraints and the increasing scale and role of the CDMO in the pharma space. 32+

  • Episode 46

    The unique general

    Andrew Moore

    / Pfizer CentreOne

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrew Moore, General Manager at Pfizer CentreOne. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrew, covering: The pride of being part of Pfizer in the last year and first-hand experience of working

  • Episode 45

    The Stickability factor

    Tom Moody

    / Almac Group

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tom Moody, Vice President of Technology Development and Commercialisation at Almac. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tom, covering: 20 years at Almac and being on a journey that has seen the

  • Episode 44

    Poacher turned gamekeeper, turned hybrid

    Peter Bigelow

    / xCell Strategic Consulting

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Bigelow President at xCell Strategic Consulting. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: The transition from being on the big pharma sponsor side at Pfizer to being head of one

  • Episode 43

    The humble leader

    Steve Ferguson

    / Medix Biochemica

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steve Ferguson, Chief Executive Officer at Medix Biochemica. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steve, covering: The positive and negative impact of Covid-19 on the diagnostic sector. And the need for more

  • Episode 42

    The understated, elite vaccine scientist.

    Archie Lovatt

    / SGS

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Archie Lovatt Life Sciences Biosafety Scientific Director at SGS. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Archie, covering: Being motivated by saving lives and seeing your contribution make a real impact on the world.

  • Episode 41

    Creating a healthy culture

    Jeff Dill

    / Vynamic

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeff Dill, CEO at Vynamic. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jeff, covering:·     How to create, document, grow and internationally scale an incredible business culture. The shift towards greater industry collaboration as

  • Episode 40

    40 at 40

    Raman Sehgal

    / ramarketing & PR Limited

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Raman Sehgal Founder & Global President of ramarketing & usual host of the Molecule to Market podcast. Raman has 20+ years of marketing and life science industry experience. Starting his career and setting up his business in the UK, Raman

  • Episode 39

    From Pfizer to CDMO start-up

    Gerry Cox

    / Velesco Pharmaceutical Services.

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gerry, covering:     The transition from two decades in Big Pharma to the

  • Episode 38

    Expanding drug dosage possibilities…

    Megan Greth and Tadgh Prendeville

    / ARx LLC

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Megan Greth, Director of Marketing & Business Development and Tadgh Prendeville, General Manager at ARx LLC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Megan and Tadgh, covering: ●    

  • Load more